CompuGroup Medical SE & Co. KGaA

100 million e-prescriptions issued in CGM’s German practice software systems

CompuGroup Medical SE & Co. KGaA publishes half-year figures for the financial year 2024

CompuGroup Medical SE & Co. KGaA expects lower revenues and therefore revises its financial year 2024 guidance

CGM receives C5 attestation according to BSI Criteria

CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok

CompuGroup Medical SE & Co. KGaA: CompuGroup Medical acquires Pridok AS

CompuGroup Medical acquires AmbulApps

CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00

CompuGroup Medical with solid first quarter against strong prior year

Share Buy-Back Program – 5th Interim Announcement, concurrently completion announcement

CompuGroup Medical successfully completes share buyback program

Share Buy-Back Program – 4th Interim Announcement

Share Buy-Back Program – 3rd Interim Announcement

CGM proposes dividend of EUR 1.00 to be passed at virtual AGM in May

CompuGroup Medical SE & Co. KGaA: Bekanntmachung der Einberufung zur Hauptversammlung am 22.05.2024 in Koblenz mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

Share Buy-Back Program – 2nd Interim Announcement

Share Buy-Back Program – 1st Interim Announcement

Launch of the Share Buy-Back Program

CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to 500,000 shares

CompuGroup Medical US announces CEO transition

CompuGroup Medical SE & Co. KGaA: Daniela Hommel, buy

CompuGroup Medical SE & Co. KGaA: Magnus Tim Rauch, buy

CompuGroup Medical SE & Co. KGaA: Julius Fynn Rauch, buy

CompuGroup Medical SE & Co. KGaA: Michael Rauch, buy

CGM plans to double its dividend